Evidence-Based Medicine Guidelines
Intratympanic gentamicin for Ménière's disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Intratympanic Gentamicin for Ménière's Disease." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/451698/all/Intratympanic_gentamicin_for_Ménière's_disease.
Intratympanic gentamicin for Ménière's disease. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/451698/all/Intratympanic_gentamicin_for_Ménière's_disease. Accessed July 28, 2025.
Intratympanic gentamicin for Ménière's disease. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/451698/all/Intratympanic_gentamicin_for_Ménière's_disease
Intratympanic Gentamicin for Ménière's Disease [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 July 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/451698/all/Intratympanic_gentamicin_for_Ménière's_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Intratympanic gentamicin for Ménière's disease
ID - 451698
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/451698/all/Intratympanic_gentamicin_for_Ménière's_disease
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
